Baba, Vevencio, JR.. S.
HRN: 14-66-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/31/2023
06/07/2023
IV
500mg
OD
T/C Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes